Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Candel Therapeutics Inc (CADL)

Candel Therapeutics Inc (CADL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Candel Therapeutics Reports Third Quarter 2024 Financial Results and Recent Corporate Highlights GlobeNewswire - Thu Nov 14, 7:00AM CST

CADL : 4.08 (+2.51%)
Candel Therapeutics to Present at Jefferies London Healthcare Conference 2024 GlobeNewswire - Thu Nov 7, 7:00AM CST

CADL : 4.08 (+2.51%)
Candel Therapeutics to Present Preclinical Data at SITC Annual Meeting Showing Promise for CAN-3110 in Melanoma, Signaling Potential Indication Expansion Beyond Recurrent High-Grade Glioma GlobeNewswire - Tue Nov 5, 8:00AM CST

CADL : 4.08 (+2.51%)
Candel Therapeutics Showcases Innovative Cancer Therapy Candidates at 16th Annual International Oncolytic Virotherapy Conference (IOVC) GlobeNewswire - Mon Oct 28, 7:00AM CDT

CADL : 4.08 (+2.51%)
Candel Therapeutics to Present Preclinical Data on Therapeutic Potential of CAN-3110 in Melanoma at SITC 2024 Annual Meeting GlobeNewswire - Fri Oct 4, 8:00AM CDT

CADL : 4.08 (+2.51%)
Biotech Innovations: Revolutionary Treatments Aim to Boost Pancreatic Cancer Survival Rates Newswire.ca - Mon Aug 12, 3:37PM CDT

/CNW/ -- USA News Group – Pancreatic cancer is among the deadliest cancers, prompting researchers to focus on early detection to improve survival rates. Johns...

ONCY : 0.9985 (unch)
HALO : 45.56 (-0.44%)
CADL : 4.08 (+2.51%)
MRUS : 44.60 (+3.89%)
RHHBY : 35.4040 (+0.78%)
ONC.TO : 1.40 (-5.41%)
Biotech Innovations Poised to Transform Pancreatic Cancer Treatment and Patient Outcomes BayStreet.ca - Mon Aug 12, 12:44PM CDT

Issued on behalf of Oncolytics Biotech Inc. VANCOUVER – USA News Group – Pancreatic cancer is among the...

ONCY : 0.9985 (unch)
ONC.TO : 1.40 (-5.41%)
RHHBY : 35.4040 (+0.78%)
HALO : 45.56 (-0.44%)
CADL : 4.08 (+2.51%)
MRUS : 44.60 (+3.89%)
Pancreatic Cancer on the Rise: How Biotech Firms are Developing Groundbreaking Treatments Newswire.ca - Wed Jun 12, 9:22AM CDT

/CNW/ -- After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may...

RHHBY : 35.4040 (+0.78%)
ONCY : 0.9985 (unch)
VSTM : 3.79 (+1.32%)
CADL : 4.08 (+2.51%)
FGEN : 0.3552 (+1.49%)
REGN : 740.20 (-0.42%)
ONC.TO : 1.40 (-5.41%)
The Fight Against Pancreatic Cancer: Biotech Firms Develop New Solutions for Rising Gen X Cases BayStreet.ca - Wed Jun 12, 9:11AM CDT

USA News Group – After looking at public health records for 3.8 million patients with invasive spreading cancer, researchers recently discovered that Generation X may be experiencing larger per-capita...

ONCY : 0.9985 (unch)
ONC.TO : 1.40 (-5.41%)
RHHBY : 35.4040 (+0.78%)
VSTM : 3.79 (+1.32%)
CADL : 4.08 (+2.51%)
FGEN : 0.3552 (+1.49%)
REGN : 740.20 (-0.42%)
Pancreatic Cancer Battle Intensifies: Biotech Innovations Aim to Boost Survival Rates Newswire.ca - Thu May 23, 10:51AM CDT

/CNW/ -- USA News Group – Known as one of the deadliest cancers, researchers are working diligently to help increase the chance of survival for pancreatic...

ONCY : 0.9985 (unch)
CADL : 4.08 (+2.51%)
AZN : 63.76 (+0.89%)
MRUS : 44.60 (+3.89%)
LTRN : 2.90 (-1.36%)
ONC.TO : 1.40 (-5.41%)

Barchart Exclusives

5 Stocks to Snag Now as Dealmaking Returns to Wall Street Barchart - 2 minutes ago
With anticipation of heightened deals in the coming year, here are 5 stocks that can benefit. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot